Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in glioma
Abstract The immunosuppressive tumor microenvironment of glioblastoma limits the effectiveness of most immunotherapies. Transforming growth factor (TGF)-β signaling drives tumor progression and prevents effective T cell activity. Notably, both regulatory T cells (Tregs) and effector T cells within g...
Saved in:
| Main Authors: | Daniela Lorizio, Manuela Silginer, Julia Friesen, Alan L. Epstein, Michael Weller, Patrick Roth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00262-025-04098-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune factors and their role in tumor aggressiveness in glioblastoma: Atypical cadherin FAT1 as a promising target for combating immune evasion
by: Manvi Arora, et al.
Published: (2025-07-01) -
Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance
by: Shriyansh Srivastava, et al.
Published: (2025-03-01) -
Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
by: Chen Chen, et al.
Published: (2025-03-01) -
Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
by: Jun Yang, et al.
Published: (2025-04-01) -
APOE Drives Glioma Progression by Modulating CCL5/CCR5 Signaling in the Tumor Microenvironment and Inducing M2 Macrophage Polarization
by: Wei Huang, et al.
Published: (2025-05-01)